Ergoteles’s Acceleron Pharma XLRN Stock Holding History

Ergoteles’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19,500	Closed	-$3.36M	–	1775
2021 Q3	$3.36M	Buy	19,500 +16,001	+457%	+$2.09M	0.12%	192
2021 Q2	$439K	Buy	+3,499	New	+$441K	0.01%	876

Ergoteles's XLRN Position: Q4 2021 in Review

Ergoteles sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 19,500 shares — an estimated $3.36M sold.

Ergoteles first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $3.36M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Ergoteles reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 19,500 Acceleron Pharma shares in Q4 2021, an estimated $3.36M.
Ergoteles first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
Ergoteles's Acceleron Pharma position peaked at $3.36M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.